SQUAWK/NEWS
Menu
Live News EQUITY M impact

Olema Pharma 8K Filing

Olema Pharmaceuticals files 8K with SEC, disclosing other events and financial statements. Regulatory disclosure and other events reported.

OLMA

Filed: 2026-05-26 AccNo: 0001193125-26-237832 Size: 597 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits